These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29066853)

  • 21. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
    Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
    [No Abstract]   [Full Text] [Related]  

  • 22. Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens.
    Takayasu K; Muramatsu Y; Mizuguchi Y; Moriyama N; Ojima H
    Intervirology; 2004; 47(3-5):199-208. PubMed ID: 15383730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomography and magnetic resonance imaging in diagnosing hepatocellular carcinoma.
    Dalla Palma L; Pozzi-Mucelli RS
    Ital J Gastroenterol; 1992 Feb; 24(2):87-91. PubMed ID: 1315593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma.
    Lencioni R; Piscaglia F; Bolondi L
    J Hepatol; 2008 May; 48(5):848-57. PubMed ID: 18328590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probability of hepatocellular carcinoma of small hepatocellular nodules undetectable by computed tomography during arterial portography.
    Tanaka Y; Sasaki Y; Katayama K; Hiramatsu N; Ito A; Murata H; Enomoto N; Oshita M; Mochizuki K; Tsujii M; Tsuji S; Kasahara A; Tomoda K; Nakamura H; Hayashi N; Hori M
    Hepatology; 2000 Apr; 31(4):890-8. PubMed ID: 10733545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
    Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
    Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].
    Vogl TJ; Eichler K; Zangos S; Mack M; Hammerstingl R
    Rofo; 2002 Nov; 174(11):1358-68. PubMed ID: 12424661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodistribution and Toxicity of X-Ray Iodinated Contrast Agent in Nano-emulsions in Function of Their Size.
    Attia MF; Anton N; Akasov R; Chiper M; Markvicheva E; Vandamme TF
    Pharm Res; 2016 Mar; 33(3):603-14. PubMed ID: 26511860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of 128 slice 4D CT whole liver perfusion imaging in hepatic tumor.
    Guo M; Yu Y
    Cell Biochem Biophys; 2014 Sep; 70(1):173-8. PubMed ID: 24691926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of contrast enhanced ultrasound (CEUS) in the assessment of liver nodules in patients with cirrhosis.
    Dănilă M; Sporea I; Sirli R; Popescu A; Sendroiu M; Martie A
    Med Ultrason; 2010 Jun; 12(2):145-9. PubMed ID: 21173943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound.
    Kambadakone AR; Fung A; Gupta RT; Hope TA; Fowler KJ; Lyshchik A; Ganesan K; Yaghmai V; Guimaraes AR; Sahani DV; Miller FH
    Abdom Radiol (NY); 2018 Jan; 43(1):56-74. PubMed ID: 28940042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging diagnosis.
    Lencioni R; Cioni D; Della Pina C; Crocetti L; Bartolozzi C
    Semin Liver Dis; 2005; 25(2):162-70. PubMed ID: 15918145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoparticle contrast-enhanced micro-CT: A preclinical tool for the 3D imaging of liver and spleen in longitudinal mouse studies.
    Liu CN; Morin J; Dokmanovich M; Bluette CT; Goldstein R; Manickam B; Bagi CM
    J Pharmacol Toxicol Methods; 2019; 96():67-77. PubMed ID: 30738209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An imaging target TGF-β1 for hepatocellular carcinoma in mice.
    Zhang Y; Li B; Li X; Tan H; Cheng D; Shi H
    Hell J Nucl Med; 2017; 20(1):76-78. PubMed ID: 28315912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration.
    Voroney JP; Brock KK; Eccles C; Haider M; Dawson LA
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):780-91. PubMed ID: 17011453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and application of strawberry-like Fe3O4-Au nanoparticles as CT-MR dual-modality contrast agents in accurate detection of the progressive liver disease.
    Zhao HY; Liu S; He J; Pan CC; Li H; Zhou ZY; Ding Y; Huo D; Hu Y
    Biomaterials; 2015 May; 51():194-207. PubMed ID: 25771010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.